We reach more than 65,000 registered users in Dec!! Register Now
AI and biobanks could open the way to longevity treatments
- November 04, 2022
- 6 Views
- 0 Likes
- 0 Comment
The development of longevity treatments is hampered with a lack of biomarkers and validated drug targets. BioAge is enlisting machine learning (ML), artificial intelligence (AI) and biobanks to fill in the gaps.
Cite This Article as
No tags found for this post